BioPlus Acquisition Corp (BIOS) Financials
$10.80
$0.00 (0.00%)As on 13-Oct-2023 09:30EDT
Market cap
$209 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
51.4
P/B Ratio
0
Div. Yield
0 %
Cashflow ($ Mln) |
TTM | Dec-22 | Dec-21 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 | Dec-13 | Dec-12 | Dec-11 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
-0.69
|
-0.84
|
-20.10
|
-0.76
|
-42.77
|
|||||
|
Cash Flow from Investing Activities
|
--
|
--
|
-255.93
|
--
|
--
|
--
|
|||||
|
Cash from Financing Activities
|
--
|
0.20
|
257.46
|
8.07
|
44.28
|
109.74
|
|||||
|
Net Cash Inflow / Outflow
|
--
|
--
|
--
|
--
|
--
|
--
|
Financials Ratios |
TTM | Dec-22 | Dec-21 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 | Dec-13 | Dec-12 | Dec-11 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS ($)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Cash EPS ($)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Adjusted Book Value ($)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Dividend per Share ($)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Cash Flow per Share ($)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Free Cash Flow per Share ($)
|
--
|
--
|
--
|
--
|
--
|
--
|
Profitability Ratios |
TTM | Dec-22 | Dec-21 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 | Dec-13 | Dec-12 | Dec-11 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
2.27
|
--
|
-11.07
|
-27.00
|
-7.57
|
|||||
|
ROE (%)
|
6.54
|
2.33
|
--
|
193.26
|
-694.96
|
-307.14
|
|||||
|
ROA (%)
|
6.29
|
2.18
|
--
|
-8.69
|
-21.64
|
-5.96
|
|||||
|
EBIT Margin (%)
|
--
|
--
|
--
|
-15.31
|
-6.45
|
-8.30
|
|||||
|
Net Margin (%)
|
334.13
|
--
|
--
|
-7.28
|
-16.03
|
-3.68
|
|||||
|
Cash Profit Margin (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
Growth Ratios |
TTM | Dec-22 | Dec-21 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 | Dec-13 | Dec-12 | Dec-11 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
--
|
--
|
--
|
-0.13
|
-0.13
|
-0.05
|
|||||
|
EBIT Growth (%)
|
516.97
|
-621.04
|
--
|
-105.88
|
32.18
|
78.33
|
|||||
|
Net Profit Growth (%)
|
-1,787.06
|
--
|
--
|
60.61
|
-280.81
|
88.67
|
|||||
|
EPS Growth (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Book Value Growth (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
Valuation Ratios |
TTM | Dec-22 | Dec-21 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 | Dec-13 | Dec-12 | Dec-11 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
51.40
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Price / Book Value
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Dividend Yield (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
EV/EBITDA
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Close Price ($)
|
10.65
|
10.22
|
--
|
--
|
--
|
--
|
|||||
|
High Price ($)
|
11.24
|
10.23
|
--
|
--
|
--
|
--
|
|||||
|
Low Price ($)
|
9.92
|
9.78
|
--
|
--
|
--
|
--
|
|||||
|
Market Cap ($ Cr)
|
209.07
|
--
|
--
|
--
|
--
|
--
|
Solvency Ratios |
TTM | Dec-22 | Dec-21 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 | Dec-13 | Dec-12 | Dec-11 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
0.04
|
0.02
|
0.02
|
-9.95
|
-178.00
|
11.19
|
|||||
|
Short term debt to equity ratio
|
0.00
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Current Ratio
|
0.10
|
1.04
|
5.60
|
1.63
|
1.79
|
1.35
|
|||||
|
Quick Ratio
|
0.10
|
--
|
--
|
1.38
|
1.42
|
1.07
|
|||||
|
Interest Coverage
|
1.96
|
-0.37
|
--
|
-1.89
|
-1.01
|
-2.03
|
Operating Efficiency Ratios |
TTM | Dec-22 | Dec-21 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 | Dec-13 | Dec-12 | Dec-11 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
--
|
--
|
--
|
16.21
|
10.46
|
11.95
|
|||||
|
Asset Turnover
|
--
|
--
|
--
|
1.19
|
1.35
|
1.62
|
|||||
|
Receivable days
|
--
|
--
|
--
|
51.63
|
44.09
|
42.98
|
|||||
|
Inventory Days
|
--
|
--
|
--
|
25.36
|
24.73
|
21.59
|
|||||
|
Payable days
|
--
|
34.81
|
--
|
52.13
|
41.70
|
33.85
|
|||||
|
Cash Conversion Cycle
|
--
|
--
|
--
|
24.85
|
27.13
|
30.72
|